Lilly eying deal with Turkish drug company

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co., GlaxoSmithKline Plc and Pfizer Inc. are among about a half-dozen companies interested in buying a stake in Mustafa Nevzat Ilac Sanayii AS in a deal that may value the Turkish drugmaker at $1 billion, three people with knowledge of the situation said.

The owners of Mustafa Nevzat, or MN Pharmaceuticals as the Istanbul-based generic drugmaker is known, have hired Bank of America Merrill Lynch to advise on the sale, said the people, who declined to be identified because the plans are confidential.

Mylan Inc. and Abbott Laboratories are also among the companies interested in bidding, they said. Merrill Lynch has sent so-called teasers to potential bidders, and non-binding bids have begun to arrive, one of the people said, adding that the process started late last year. Preliminary bidding may be completed within two months, one of the people said.

Two other Turkish pharmaceutical companies—Abdi Ibrahim Ilac Sanayi & Ticaret, the country’s largest, and Biofarma Pharmaceutical Industry Co.—have failed in efforts to sell stakes over the past two years. While Glaxo is seeking deals in emerging markets, it’s becoming harder to find acquisitions that make “financial sense,” CEO Andrew Witty said last year.

MN’s owners, the children and grandchildren of the founder Mustafa Nevzat Pisak, have yet to decide whether to sell a minority or majority stake in the closely held company, two of the people said. The owners are seeking a price that values the company at 15 to 20 times earnings before interest, tax, depreciation and amortization, or Ebitda, one of the people said.

Turkey has been a popular target for deals in recent years, with companies seeking to tap its $735 billion economy, which grew 8.2 percent in the third quarter of 2011, the fastest rate among the Group of 20 countries after China.

Zentiva NV, a Czech drugmaker bought by Sanofi in 2009, bought 75 percent of the generic-drug unit of Turkey’s Eczacibasi in 2007 for $613 million, and later purchased the remaining 25-percent stake.

Cengiz Sezen, MN’s chairman, and CEO Levent Selamoglu didn’t respond to e-mailed questions about possible talks or return phone calls seeking comment.

Glaxo, the United Kingdom’s largest drugmaker, is interested in acquiring a pharmaceutical company in Turkey as it struggles to become profitable in the country, the newspaper Hurriyet said Jan. 29, citing Abbas Hussain, the drugmaker’s emerging markets president. Sarah Spencer, a Glaxo spokeswoman, declined to comment on whether MN is a potential target. Spokesmen for Abbott, Eli Lilly, Mylan and Pfizer also declined to comment.

MN was the first Turkish pharmaceutical company to win a license from the Food and Drug Administration to sell products in the U.S., according to the company’s website. International companies sought to do business with Mustafa Nevzat since it acquired the FDA license in 2006, Selamoglu said in an interview Sept. 28.

The company’s products are largely injectable medications, Selamoglu said. They range from antidepressants to diabetic treatments and antipsychotic agents, according to its website.

Eli Lilly and MN were in negotiations that had reached an “advanced stage” to sell drugs in 26 countries in South America, Asia, Europe and Africa, Selamoglu said at the time.

MN generates annual revenue of about $250 million by selling about 100 million boxes of its products in Turkey, Selamoglu said. The country’s drug market was $9.2 billion in 2010, according to the website of the Istanbul-based Pharmaceutical Manufacturers Association of Turkey.



Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ
  1. From the story: "The city of Indianapolis also will consider tax incentives and funding for infrastructure required for the project, according to IEDC." Why would the City need to consider additional tax incentives when Lowe's has already bought the land and reached an agreement with IEDC to bring the jobs? What that tells me is that the City has already pledged the incentives, unofficially, and they just haven't had time to push it through the MDC yet. Either way, subsidizing $10/hour jobs is going to do nothing toward furthering the Mayor's stated goal of attracting middle and upper-middle class residents to Marion County.

  2. Ron Spencer and the entire staff of Theater on the Square embraced IndyFringe when it came to Mass Ave in 2005. TOTS was not only a venue but Ron and his friends created, presented and appeared in shows which embraced the 'spirit of the fringe'. He's weathered all the storms and kept smiling ... bon voyage and thank you.

  3. Not sure how many sushi restaurants are enough, but there are three that I know of in various parts of downtown proper and all are pretty good.

  4. First off, it's "moron," not "moran." 2nd, YOU don't get to vote on someone else's rights and freedoms that are guaranteed by the US Constitution. That's why this is not a state's rights issue...putting something like this to vote by, well, people like you who are quite clearly intellectually challenged isn't necessary since the 14th amendment has already decided the issue. Which is why Indiana's effort is a wasted one and a waste of money...and will be overturned just like this has in every other state.

  5. Rick, how does granting theright to marry to people choosing to marry same-sex partners harm the lives of those who choose not to? I cannot for the life of me see any harm to people who choose not to marry someone of the same sex. We understand your choice to take the parts of the bible literally in your life. That is fine but why force your religious beliefs on others? I'm hoping the judges do the right thing and declare the ban unconstitutional so all citizens of Wisconsin and Indiana have the same marriage rights and that those who chose someone of the same sex do not have less rights than others.